Thursday, February 19, 2026 12:06 AM ET
8 hours ago
FDA agrees to review Moderna's mRNA flu vaccine application in a reversal12 hours ago
FDA chief Marty Makary says more drugs should be available over the counter12 hours ago
Danaher is tapping the M&A well yet again. But we might have had enough1 day ago
French prosecutors investigate Nestle, Danone over contaminated baby formula1 day ago
Novo Nordisk faces a defining year in the obesity drug market2 days ago
How largest health-care education company in U.S. is tackling growing jobs gap7 days ago
Novo CEO sees 15 million patient opportunity in Medicare obesity coverage7 days ago
Moderna says FDA refuses to review its application for experimental flu shot8 days ago
CVS tops quarterly estimates, reaffirms profit outlook as turnaround takes hold8 days ago
Florida law models what genetic disease testing could be8 days ago
FDA says Novo Nordisk's TV ad for obesity pill includes misleading claims8 days ago
Novo Nordisk sues Hims & Hers over copycat versions of Wegovy pill, injections9 days ago
Hims & Hers stops offering weight loss pill after threats of legal action9 days ago
Healthy Returns: Pfizer execs chart out obesity drug strategy11 days ago
White House launches direct-to-consumer drug site TrumpRx. Here's what to know13 days ago
Eli Lilly sees GLP-1 growth accelerating as Novo Nordisk braces for a decline13 days ago
Eli Lilly blows past quarterly estimates, posts strong outlook as GLP-1 sales soar14 days ago
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial15 days ago
Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook15 days ago
Merck tops quarterly estimates, posts modest outlook as generic competition looms15 days ago
Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch15 days ago
Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs19 days ago
As ACA subsidies expire, health costs emerge as top economic worry for voters: survey19 days ago
Breakthrough drug helps 11-year-old battle rare neurological gene mutation19 days ago
Healthy Returns: 15 drugs added to Medicare price negotiations19 days ago
Danaher stock fails to rise on solid earnings — leading us to question what's next21 days ago
UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround21 days ago
Next up in weight loss drugs: More pills, easier access and drug combinations22 days ago
Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s26 days ago
Amazon launches AI health-care tool for One Medical members28 days ago
OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion28 days ago
Another alliance of health care and AI signals why pharma stocks could be back28 days ago
Drug pricing, patent losses, deals: What pharma execs see ahead in the industry29 days ago